Ketamine Therapy for Seniors: A Safety Guide

One of the hardest conversations I have goes like this: a woman in her late sixties calls on behalf of her husband, who has been depressed since his retirement three years ago. His primary care doctor tried Lexapro, then Zoloft, then Wellbutrin. Nothing helped. When she asked the doctor what else they could try, he shrugged and said depression was common at their age, implying, without quite saying it, that her husband should learn to live with it. She doesn't want him to live with it. She wants him back.

That assumption (that depression in older adults is a natural feature of aging and not a medical condition worth treating aggressively) is one of the most persistent failures in American psychiatry, and it costs people years of life they could be enjoying. About one in six adults over sixty meets criteria for clinically significant depression, and the response rate to first-line antidepressants in this population is roughly what it is in younger adults. Treatment-resistant depression in seniors is not a sign that treatment has reached its limit. It's a sign that a different treatment is warranted. Ketamine, used carefully, is often that different treatment.

Age Is Not an Automatic Disqualifier

Let me be clear from the outset: being over 60, 70, or even 80 does not automatically disqualify you from ketamine therapy. Age alone is not a contraindication. What matters is your overall health profile: cardiovascular status, kidney and liver function, cognitive baseline, medication list, and fall risk.

Many older adults are excellent candidates for ketamine therapy. They often have the stability, patience, and support systems that contribute to good treatment outcomes. The key is thorough evaluation and appropriate modifications to standard protocols.

Cardiovascular Considerations

The most important age-related concern with ketamine therapy is cardiovascular. Ketamine can temporarily raise blood pressure and heart rate during treatment sessions. In younger, cardiovascularly healthy patients, this is typically a minor and self-limiting effect. In older adults, it requires more careful attention.

Blood pressure monitoring. At Tovani Health, we require all patients to have a home blood pressure monitor. For patients over 60, blood pressure measurements before and during treatment sessions are particularly important. We establish a baseline and set clear parameters for when treatment should not proceed (for example, if pre-treatment blood pressure exceeds specific thresholds).

Existing hypertension. Well-controlled hypertension on medication is not an automatic disqualifier. However, uncontrolled hypertension or poorly managed blood pressure does require attention before beginning ketamine therapy. In some cases, we work with your primary care physician or cardiologist to optimize blood pressure management before initiating treatment.

Cardiovascular history. Patients with a history of heart attack, stroke, aortic aneurysm, or other significant cardiovascular events require individual risk assessment. Some cardiovascular histories are absolute contraindications; others can be managed with appropriate precautions. Your Tovani Health clinician will evaluate your specific situation during the eligibility assessment.

Heart rate. Ketamine's sympathomimetic effects can increase heart rate by 10 to 20 beats per minute. For most older adults, this is well-tolerated. For patients with arrhythmias or rate-controlled cardiac conditions, this needs to be discussed with your cardiologist.

Medication Interactions in Older Adults

Polypharmacy (taking multiple medications simultaneously) is extremely common in patients over 60. The average older adult takes five or more prescription medications. Each additional medication creates potential for interactions, and ketamine's safety profile must be evaluated in the context of everything else you are taking.

Medications that require particular attention when considering ketamine therapy include:

• Blood pressure medications. These may need timing adjustments on treatment days to avoid excessive blood pressure drops after ketamine's transient hypertensive effect resolves.
• Benzodiazepines (such as lorazepam, clonazepam, or diazepam). These can blunt ketamine's therapeutic effects and increase sedation risk. Dose adjustments may be needed.
• Opioid pain medications. Combined sedative effects require careful dose management.
• Anticholinergic medications. Common in older adults for conditions like overactive bladder and allergies, these can contribute to cognitive effects when combined with ketamine.
• Lithium and lamotrigine. These require specific evaluation for potential interactions.
• Blood thinners. While not directly interacting with ketamine, fall risk during dissociation makes the consequences of any fall more serious for patients on anticoagulants.

During your evaluation, we review every medication (prescription, over-the-counter, and supplements) to identify potential interactions and develop a safe treatment plan.

Fall Prevention During Treatment

Falls are a leading cause of injury and hospitalization in older adults. Ketamine produces dissociation and impaired coordination during treatment sessions, which elevates fall risk. This is manageable but requires planning.

Treatment setting preparation:

• Conduct sessions in a ground-floor room if possible
• Remove tripping hazards (loose rugs, cords, clutter) from the treatment area and path to the bathroom
• Have a sturdy chair or grab bar available near the treatment area
• Keep a clear, short path between the treatment space and the nearest bathroom
• Use nightlights if the session occurs in the evening

Support person role. The support person requirement applies to all patients but is especially critical for older adults. Your support person should be physically capable of providing stability assistance if you need to stand during or after treatment. They should help you to and from the bathroom and ensure you do not attempt stairs during the acute effect period.

Post-session precautions. Remain seated or reclined until you feel fully steady. When you do stand, do so slowly to avoid orthostatic hypotension (a drop in blood pressure upon standing, which is more common in older adults). Have your support person nearby when you first stand and walk after treatment.

Kidney and Liver Function

Ketamine is metabolized by the liver and its metabolites are excreted by the kidneys. Age-related decline in liver and kidney function can affect how your body processes the medication.

For patients over 60, we may:

• Request recent lab work showing kidney and liver function markers
• Start with lower doses and adjust based on response and tolerability
• Space sessions slightly further apart to allow more complete metabolism between treatments
• Monitor for any signs of accumulation effects

Mildly reduced kidney or liver function is common in older adults and does not necessarily prevent treatment. Significantly impaired function requires careful individual assessment.

Cognitive Considerations

One concern sometimes raised about ketamine therapy in older adults is its potential effect on cognition. Here is what the evidence shows:

Acute effects. During a ketamine session, cognition is temporarily impaired; this is expected and resolves within hours. This acute impairment is the same in older and younger adults.

Long-term cognitive effects. At therapeutic doses and frequencies used for depression treatment, there is no evidence that ketamine causes lasting cognitive impairment in older adults. This is an important distinction from chronic, high-dose recreational use, which is associated with cognitive effects.

Depression itself impairs cognition. This is worth emphasizing. Untreated depression in older adults causes significant cognitive impairment, often called "pseudodementia" because it mimics dementia. Successfully treating depression with ketamine often improves cognitive function rather than worsening it.

Pre-existing cognitive impairment. Patients with diagnosed dementia or significant cognitive decline require individual evaluation. Mild cognitive impairment is not necessarily a contraindication, but it affects informed consent processes and may require family involvement in treatment decisions.

Medicare and Insurance Considerations

Most older adults are covered by Medicare, which currently does not cover off-label ketamine therapy for depression. This means treatment through Tovani Health is an out-of-pocket expense for Medicare beneficiaries.

Advance Beneficiary Notice (ABN). While Tovani Health does not bill Medicare for ketamine therapy services, you may encounter ABN-related paperwork if any component of your care touches Medicare-covered services. We will explain any relevant financial obligations clearly during your evaluation.

Supplemental insurance. Some Medicare supplement plans may offer mental health benefits that partially offset treatment costs. This varies by plan and is worth investigating with your insurance provider.

Cost perspective. While the out-of-pocket cost is a real consideration, many seniors and their families find that the value of effective depression treatment (in terms of quality of life, independence, and reduced healthcare utilization from untreated depression) justifies the investment.

What Family Members Should Know

If you are the adult child or caregiver of a senior considering ketamine therapy, your involvement is valuable. Here are the key points:

• Ketamine therapy can be safe for older adults with appropriate medical screening
• Your role as a support person during treatment sessions is especially important
• Blood pressure monitoring and fall prevention are the primary safety priorities
• The treatment will not cause lasting cognitive changes at prescribed therapeutic doses
• Depression is not normal aging, and your loved one deserves effective treatment
• Open communication with the treatment team about any concerns is always welcome

Moving Forward With Confidence

Late-life depression responds to treatment. The narrative that older adults simply have to accept depression as part of aging is contradicted by decades of clinical evidence. Ketamine therapy represents a particularly promising option for seniors who have not responded to traditional antidepressants, offering rapid improvement through mechanisms that do not depend on the same pathways as the medications that have already been tried.

Frequently Asked Questions

Is ketamine therapy safe for seniors over 60?

Yes, for appropriately screened patients. Age alone is not a contraindication. What matters is overall health profile: cardiovascular status, kidney and liver function, cognitive baseline, current medications, and fall risk. Many adults in their 60s, 70s, and 80s are excellent candidates with stability, patience, and support systems that often produce better outcomes than younger patients. The eligibility evaluation specifically reviews age-relevant factors before approval.

How are ketamine protocols modified for older patients?

Several adjustments are common. Lower starting doses with gradual upward titration based on response (older adults can be more sensitive to dissociation). More structured blood-pressure monitoring before, during, and after sessions; ketamine causes a transient BP rise that's a non-event for healthy adults but warrants extra attention with cardiovascular comorbidities. Fall-risk planning during the 6-hour post-session window (bathroom layout, support person availability, no nighttime sessions for patients who need to navigate stairs). More attention to drug-interaction review with the medication list, which is often longer at this age.

Will Medicare cover ketamine therapy for seniors?

Generally no for racemic ketamine. Medicare doesn't cover off-label psychiatric ketamine, same as private insurance. Spravato (esketamine, FDA-approved for TRD) IS covered by Medicare Part B for treatment-resistant depression, typically requiring documented failure of two prior antidepressants, REMS-certified clinic visits, and substantial copays. Out-of-pocket costs for at-home racemic ketamine ($349/month plus medication) often run lower than the copay structure for Medicare-covered Spravato visits.

What if a senior has multiple medications, is the interaction risk too high?

Polypharmacy in seniors is real but rarely a deal-breaker. Most common medication categories (SSRIs, SNRIs, atypicals, blood-pressure medications, statins, diabetes medications, thyroid replacement) are compatible with at-home ketamine. The flags worth checking carefully: MAOIs (true contraindication, requires washout), high-dose benzodiazepines (may blunt response), opioids (manageable but worth coordinating with the prescribing pain provider), and anticoagulants (no direct interaction but worth flagging in case of unusual bleeding). The medication review during the eligibility evaluation handles this systematically.

Ready to evaluate ketamine for late-life depression?

If you or a loved one over 60 is living with depression that has not responded adequately to treatment, here is the entry point. Our evaluation carefully considers all age-related factors to ensure treatment is both safe and effective for your specific situation.

• Eligibility check: tovanihealth.com/eligibility (5 minutes, FL and NJ residents)
• Phone: 561-468-6981
• What you get back: an honest answer including age-specific safety considerations and a clear next step.

Benjamin Soffer, DO — Tovani Health

Related reading: safety protocols, side effects and risks, treatment-resistant depression, ketamine with benzodiazepines (relevant for many older adults on anxiety medications).